Monday, April 8, 2013
Chimerix Scheduled to Go Public This Week
Durham's drug-development company Chimerix Inc. is readying to go public on April 11 and will trade under the Nasdaq symbol CMRX when – and if – it makes its debut. The initial offering is being priced at $13-$15 per share.
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment